Saphnelo (anifrolumab-fnia)

Adult Dosing .

Dosage forms:  INJ

Special Note

[formulation clarification]

Info: nonproprietary name = anifrolumab-fnia

moderate-severe SLE, adjunct tx

[300 mg IV q4wk]

renal dosing

[see below]

eGFR >30: no adjustment; eGFR <30 or ESRD: not defined

HD/PD: not defined

hepatic dosing

[no adjustment]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.